These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9250859)
1. Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog. Kobayashi T; Urakami S; Cheadle JP; Aspinwall R; Harris P; Sampson JR; Hino O Mamm Genome; 1997 Aug; 8(8):554-8. PubMed ID: 9250859 [TBL] [Abstract][Full Text] [Related]
2. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. Tsuchiya H; Orimoto K; Kobayashi K; Hino O Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946 [TBL] [Abstract][Full Text] [Related]
3. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Yeung RS; Xiao GH; Jin F; Lee WC; Testa JR; Knudson AG Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11413-6. PubMed ID: 7972075 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish. Maheshwar MM; Sandford R; Nellist M; Cheadle JP; Sgotto B; Vaudin M; Sampson JR Hum Mol Genet; 1996 Jan; 5(1):131-7. PubMed ID: 8789450 [TBL] [Abstract][Full Text] [Related]
5. cDNA structure, alternative splicing and exon-intron organization of the predisposing tuberous sclerosis (Tsc2) gene of the Eker rat model. Kobayashi T; Nishizawa M; Hirayama Y; Kobayashi E; Hino O Nucleic Acids Res; 1995 Jul; 23(14):2608-13. PubMed ID: 7651821 [TBL] [Abstract][Full Text] [Related]
6. Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells. Orimoto K; Tsuchiya H; Kobayashi T; Matsuda T; Hino O Biochem Biophys Res Commun; 1996 Feb; 219(1):70-5. PubMed ID: 8619830 [TBL] [Abstract][Full Text] [Related]
7. TSC2 gene mutant (Eker) rat model of a Mendelian dominantly inherited cancer. Hino O; Fukuda T; Satake N; Kobayashi T; Honda S; Orimoto K; Yamashita Y; Kikuchi Y Prog Exp Tumor Res; 1999; 35():95-108. PubMed ID: 10377754 [No Abstract] [Full Text] [Related]
8. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281 [TBL] [Abstract][Full Text] [Related]
9. Ets protein Elf-1 bidirectionally suppresses transcriptional activities of the tumor suppressor Tsc2 gene and the repair-related Nth1 gene. Honda S; Kobayashi T; Kajino K; Urakami S; Igawa M; Hino O Mol Carcinog; 2003 Jul; 37(3):122-9. PubMed ID: 12884363 [TBL] [Abstract][Full Text] [Related]
10. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170 [TBL] [Abstract][Full Text] [Related]
11. [Cancer genetics of TSC2 gene mutant(Eker) rat model]. Hino O Nihon Rinsho; 2000 Jun; 58(6):1255-61. PubMed ID: 10879050 [TBL] [Abstract][Full Text] [Related]
12. Mutations in the TSC2 gene: analysis of the complete coding sequence using the protein truncation test (PTT). van Bakel I; Sepp T; Ward S; Yates JR; Green AJ Hum Mol Genet; 1997 Sep; 6(9):1409-14. PubMed ID: 9285776 [TBL] [Abstract][Full Text] [Related]
13. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Kobayashi T; Hirayama Y; Kobayashi E; Kubo Y; Hino O Nat Genet; 1995 Jan; 9(1):70-4. PubMed ID: 7704028 [TBL] [Abstract][Full Text] [Related]
14. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell. Urakami S; Tokuzen R; Tsuda H; Igawa M; Hino O J Urol; 1997 Jul; 158(1):275-8. PubMed ID: 9186374 [TBL] [Abstract][Full Text] [Related]
15. Interstitial chromosomal deletion of the tuberous sclerosis complex 2 locus is a signature for radiation-associated renal tumors in Eker rats. Inoue T; Kokubo T; Daino K; Yanagihara H; Watanabe F; Tsuruoka C; Amasaki Y; Morioka T; Homma-Takeda S; Kobayashi T; Hino O; Shimada Y; Kakinuma S Cancer Sci; 2020 Mar; 111(3):840-848. PubMed ID: 31925975 [TBL] [Abstract][Full Text] [Related]
16. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Rennebeck G; Kleymenova EV; Anderson R; Yeung RS; Artzt K; Walker CL Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15629-34. PubMed ID: 9861021 [TBL] [Abstract][Full Text] [Related]
17. Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (Tsc2). Hino O; Kobayashi E; Hirayama Y; Kobayashi T; Kubo Y; Tsuchiya H; Kikuchi Y; Mitani H Mol Carcinog; 1995 Sep; 14(1):23-7. PubMed ID: 7546221 [TBL] [Abstract][Full Text] [Related]
19. Identification of a core promoter and a novel isoform of the human TSC1 gene transcript and structural comparison with mouse homolog. Ali M; Girimaji SC; Kumar A Gene; 2003 Nov; 320():145-54. PubMed ID: 14597398 [TBL] [Abstract][Full Text] [Related]
20. Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Au KS; Rodriguez JA; Finch JL; Volcik KA; Roach ES; Delgado MR; Rodriguez E; Northrup H Am J Hum Genet; 1998 Feb; 62(2):286-94. PubMed ID: 9463313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]